Oppilan Pharma Ltd

Biotechnology company · London, England, United Kingdom

Oppilan Pharma Ltd is a biotechnology company headquartered in London, England, United Kingdom. Its earliest recorded incorporation is in 2015. It has reported private securities offerings to the US SEC, most recently $4.3 million sold in a notice filed in 2016. It is registered with UK Companies House under company number 09610773.

Profile compiled from public records. Is this your company? Request a correction or update

Oppilan Pharma at a glance

Typebiotechnology company

HeadquartersLondon, England, United Kingdom

Earliest incorporation on record2015

Registered activities (UK)Research and experimental development on biotechnology

UK company number09610773

SEC CIK1693601

What does Oppilan Pharma do?

Private fundraising reported to the SEC

1 Form D notice; the most recent reported $4.3 million sold (2016).

Frequently asked questions about Oppilan Pharma

Where is Oppilan Pharma headquartered?

Oppilan Pharma Ltd is headquartered in London, England, United Kingdom.

What does Oppilan Pharma do?

Oppilan Pharma Ltd is a biotechnology company.

When was Oppilan Pharma founded?

The earliest incorporation on record for Oppilan Pharma Ltd is in 2015, according to public company registers.

Similar companies

Orchard Therapeutics plcLondon, England, United Kingdom
Gyroscope Therapeutics LtdLondon, England, United Kingdom
CHARM Therapeutics Inc.London, England, United Kingdom
Duke Street Bio LtdLondon, England, United Kingdom
Autolus Therapeutics plcLondon, England, United Kingdom
OKYO Pharma LtdLondon, England, United Kingdom
Beacon Therapeutics LimitedLondon, England, United Kingdom
Meiragtx UK Ii LimitedLondon, England, United Kingdom

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences